UK's antibiotic crisis looms as China controls 90% of global supply chains

Britain’s healthcare system could face severe disruptions within weeks if China restricts medical exports or tensions escalate. A new report highlights the country’s heavy reliance on Chinese-supplied antibiotics, leaving the NHS and military vulnerable. Experts warn that even outside of war, a sudden supply squeeze could cripple access to essential medicines. China dominates the global antibiotics supply chain, producing up to 90% of the key ingredients used in British medications. Only seven factories worldwide manufacture the core compound for penicillin—and all are in China. This concentration creates a critical chokepoint, where any export ban or industrial failure could halt production almost overnight.

India, which provides most antibiotics to the UK and US, depends on China for 91.5% of its raw materials. The top four Chinese suppliers alone account for over half of India’s imports, deepening the West’s vulnerability. Years of price suppression by Chinese manufacturers have also pushed Western producers out of the market, leaving just one penicillin plant operating in Austria. The risks extend beyond wartime scenarios. A ‘health blockade’—where China restricts supplies to India—could starve Britain and Europe of vital drugs. Military forces and hospitals would face immediate shortages, with no quick alternatives available.

The report urges Western governments to rebuild antibiotic production outside China and India. Without action, Britain’s healthcare and defence sectors remain exposed to sudden supply cuts. A single export restriction or geopolitical shift could leave the NHS and Armed Forces without critical medications in a matter of weeks.